Clinical Trial

Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the time of cataract surgery is more or less effective than the others. The primary outcomes are to compare intraocular pressure control and glaucoma medication use up to 6 months after surgery. Participants will under combined cataract surgery and goniotomy. They will have post-operative follow up visits at 1 day, 1 week, 1 month, 3 months, and 6 month
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-11.
Trial Details
NCT Number NCT07418853
Lead Sponsor Henry Ford Health System
Conditions Open Angle Glaucoma (OAG), Primary Open Angle Glaucoma (POAG), Secondary Open Angle Glaucoma
Enrollment 132 participants
Start Date 2026-07-01
Primary Completion 2028-03-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-11